| PipeLine is a best-in-class desktop software tool–it helps program managers plan optimal procurement and delivery schedules for health commodities, and it monitors their orders throughout the supply chain. Policymakers, product suppliers, and donors can generate reports, estimate future product needs, and use the software as a key tool in program planning. This effective tool has been used in more than 40 countries around the world, with products in reproductive health, essential medicines, anti-retroviral testing and treatment, malaria testing and treatment, lab supplies, and tuberculosis treatment.
PipeLine Version 5.1 is an upgrade to the 2010 release, Version 5.0. It adds one new feature, provides the software in three additional languages, and resolves several outstanding issues experienced by some users of PipeLine 5.0. New features in PipeLine version 5.1 enhance forecast data entry. Features added in version 5.0 (which continue in version 5.1) include new fields and reports allow you to describe and display details of shipments and consumption of health commodities for virtually any type of product.
- Regions/Countries:
- Global |
- Global
WHO Upholds Guidance: Women With or at Risk of HIV Can Safely Use Hormonal Methods
WHO released a statement on February 16, 2012, upholding guidance indicating that women with HIV or at high risk of HIV can safely use hormonal contraceptives, including injectables, to prevent pregnancy. However, WHO is instructing health care providers to strongly advise such women who decide to use progestin-only injectables to also always use male or female condoms for protection against HIV. Read more about WHO's statement.
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.